Key facts
- miDiagnostics’s last known valuation is $294.6M.
- It has raised $216.7M; the latest was Later Stage VC ($23.0M) in Dec 2024.
- Notable investors include Participatiemaatschappij Vlaanderen, Alychlo, VMF Invest, Imec, Johns Hopkins Technology Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for miDiagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for miDiagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About miDiagnostics
Developer of chip-based technology designed to bring miniaturized lab-quality tests with built-in connectivity. The company's technology combines a nanofluidic processor on a chip and a compact reader to measure virtually any biomarker from easy-to-access samples such as finger-prick blood or nasal swabs, enabling patients and clinicians to provide rapid diagnostics anywhere and at any time.
- Sector
- Healthcare
- HQ
- Leuven, Belgium
- Founded
- 2015
- Employees
- 70
- Website
- midiagnostics.com/
- Ownership
- Privately Held (backing)
miDiagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in miDiagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on miDiagnostics in its N-PORT filings yet. We sweep new filings monthly.